|
⚲
|
| Keyboard |
| Reid Huber | |
|---|---|
| Firm | |
| Address | c/o Asher Biotherapeutics, Inc 650 Gateway Blvd, Suite 100 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Asher Biotherapeutics Inc | 021-510726 | Director | 55.0 M of 55.0 M |
||
| Synnovation Therapeutics Inc | 021-499739 | Director | 15.0 M of 102.5 M |
||
| Tango Therapeutics Inc | 021-490627 | Director | 80.0 M of 80.0 M |
||
| Synnovation Therapeutics Inc | 021-482506 | Director | 25.0 M of 25.0 M |
||
| Asher Biotherapeutics Inc | 021-412545 | Director | 108.0 M of 108.0 M |
||
| Third Rock Ventures LLC | |||||
| Third Rock Ventures VI LP | 021-448880 | Executive Officer | 1,105.3 M of 1,105.3 M |
786.6 M | |
| Third Rock Ventures V LP | 021-341395 | Executive Officer | 750.0 M of 750.0 M |
736.1 M | |